Autoimmune hepatitis in teenage pregnancy with good obstetric outcome.

BMJ Case Rep

Obstetrics and Gynaecology, Wrexham Maelor Hospital, Betsi Cadwaladr University Health Board, North Wales, UK.

Published: June 2024

AI Article Synopsis

Article Abstract

Autoimmune hepatitis (AIH) is a rare liver disorder having long-standing inflammatory features. It classically affects women of reproductive age and can have adverse maternal and fetal outcomes during the pregnancy. The course of the disease is unpredictable and there have been flares even in stable patients. There are limited reports of its management in pregnancy. Furthermore, clinicians may encounter more pregnancies complicated by AIH due to advances in the treatment of AIH. We report a case of unplanned pregnancy in a young teenager who had been diagnosed with AIH. This case report summarises the risks, investigations, treatment and prevention of complications to achieve a favourable outcome in pregnancy. We highlight the importance of tight surveillance by a multidisciplinary team involving maternal medicine specialists and hepatology teams to achieve a good obstetric outcome in a district hospital like ours.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2024-259698DOI Listing

Publication Analysis

Top Keywords

autoimmune hepatitis
8
good obstetric
8
obstetric outcome
8
pregnancy
5
hepatitis teenage
4
teenage pregnancy
4
pregnancy good
4
outcome autoimmune
4
aih
4
hepatitis aih
4

Similar Publications

Background And Aim: Discriminating between idiosyncratic drug-induced liver injury (DILI) and autoimmune hepatitis (AIH) is critical yet challenging. We aim to develop and validate a machine learning (ML)-based model to aid in this differentiation.

Methods: This multicenter cohort study utilised a development set from Beijing Friendship Hospital, with retrospective and prospective validation sets from 10 tertiary hospitals across various regions of China spanning January 2009 to May 2023.

View Article and Find Full Text PDF

Autoimmune hepatitis (AIH) is a rare chronic inflammatory liver disease characterized by the presence of autoantibodies, including those targeting O-phosphoseryl-tRNA:selenocysteine-tRNA synthase (SepSecS), also known as soluble liver antigen (SLA). Anti-SepSecS antibodies have been associated with a more severe phenotype, suggesting a key role for the SepSecS autoantigen in AIH. To analyze the immune response to SepSecS in patients with AIH at the clonal level, we combined sensitive high-throughput screening assays with the isolation of monoclonal antibodies (mAbs) and T cell clones.

View Article and Find Full Text PDF

How are autoreactive T cells induced and regulated in patients with autoimmune disease? This question lies at the core of understanding autoimmune disease pathologies, yet it has remained elusive due to host variability and the complexity of the immune system. In this issue of the JCI, Kramer and colleagues used autoimmune hepatitis (AIH) as a model to explore the maintenance of autoreactive CD4+ T cells specific to O-phosphoseryl-tRNA:selenocysteine tRNA synthase (SepSecS). The findings provide insight into the interaction between T cells and B cells in AIH pathogenesis that may reflect a shared mechanism among other autoimmune diseases.

View Article and Find Full Text PDF

Introduction/objectives: The study aimed to determine whether in children with newly diagnosed juvenile idiopathic arthritis (JIA) hepatitis B surface antibody (anti-HBs) differs from healthy children and to see whether the revaccination is safe and effective under JIA treatment.

Methods: Patients who were followed up with a diagnosis of JIA between January 2020 and February 2024 were included. The control group consisted of healthy children matched for age and gender.

View Article and Find Full Text PDF

Cryoglobulinemic vasculitis is a rare small-vessel vasculitis leading to multi-organ dysfunction, often associated with chronic infections like hepatitis C virus (HCV), and autoimmune disorders. Most cases involve mixed monoclonal or polyclonal immunoglobulins, presenting symptoms such as purpura, arthralgias, and weakness. Severe organ involvement, particularly cardiac, is rare but potentially life-threatening.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!